These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34693624)

  • 21. Whole-genome sequencing links Clostridium (Clostridioides) difficile in a single hospital to diverse environmental sources in the community.
    Lim SC; Collins DA; Imwattana K; Knight DR; Perumalsamy S; Hain-Saunders NMR; Putsathit P; Speers D; Riley TV
    J Appl Microbiol; 2022 Sep; 133(3):1156-1168. PubMed ID: 34894035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
    Lachowicz D; Pituch H; Obuch-Woszczatyński P
    Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.
    Zhou Y; Burnham CA; Hink T; Chen L; Shaikh N; Wollam A; Sodergren E; Weinstock GM; Tarr PI; Dubberke ER
    J Clin Microbiol; 2014 Dec; 52(12):4260-6. PubMed ID: 25275005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.
    Ilchmann C; Zaiss NH; Speicher A; Christner M; Ackermann G; Rohde H
    Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1571-3. PubMed ID: 20632051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia.
    Lim SC; Androga GO; Knight DR; Moono P; Foster NF; Riley TV
    Int J Antimicrob Agents; 2018 Sep; 52(3):411-415. PubMed ID: 29802886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the phylogenetics and resistome of the major
    O'Grady K; Hong S; Putsathit P; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Levy A; Moore CV; Nimmo G; Prendergast L; Robson J; Speers DJ; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    Microb Genom; 2024 May; 10(5):. PubMed ID: 38717815
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China.
    Wang B; Lv Z; Zhang P; Su J
    Medicine (Baltimore); 2018 Jun; 97(25):e11219. PubMed ID: 29924052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
    Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile.
    Collins DA; Wu Y; Tateda K; Kim HJ; Vickers RJ; Riley TV
    J Antimicrob Chemother; 2021 Mar; 76(4):967-972. PubMed ID: 33351917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.
    Spigaglia P; Barbanti F; Dionisi AM; Mastrantonio P
    J Clin Microbiol; 2010 Aug; 48(8):2892-6. PubMed ID: 20554809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization and antibiotic resistance of Clostridioides difficile in patients with inflammatory bowel disease from two hospitals in China.
    Lv T; Zheng L; Wu T; Shen P; Chen Y
    J Glob Antimicrob Resist; 2022 Sep; 30():252-258. PubMed ID: 35764214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from hospitals during a 4-year period in China.
    Chen YB; Gu SL; Shen P; Lv T; Fang YH; Tang LL; Li LJ
    J Med Microbiol; 2018 Jan; 67(1):52-59. PubMed ID: 29160203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing clade 2 ribotype 251 strain.
    Wehrhahn MC; Keighley C; Kurtovic J; Knight DR; Hong S; Hutton ML; Lyras D; Wang Q; Leong R; Borody T; Edye M; Riley TV
    Anaerobe; 2019 Feb; 55():117-123. PubMed ID: 30500477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile clade 5 in Australia: antimicrobial susceptibility profiling of PCR ribotypes of human and animal origin.
    Knight DR; Riley TV
    J Antimicrob Chemother; 2016 Aug; 71(8):2213-7. PubMed ID: 27130808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Clostridioides difficile isolates recovered from two Phase 3 surotomycin treatment trials by restriction endonuclease analysis, PCR ribotyping and antimicrobial susceptibilities.
    Cheknis A; Devaris D; Chesnel L; Dale SE; Nary J; Sambol SP; Citron DM; Goering RV; Johnson S
    J Antimicrob Chemother; 2020 Nov; 75(11):3120-3125. PubMed ID: 32747931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial-resistant strains of Clostridium difficile from North America.
    Tenover FC; Tickler IA; Persing DH
    Antimicrob Agents Chemother; 2012 Jun; 56(6):2929-32. PubMed ID: 22411613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.